-
Nov 12, 2024 | 
einpresswire.com | Clinical Laboratories
AUSTIN, TX, UNITED STATES, November 12, 2024 / EINPresswire.com/ -- According to Research by S&S Insider, The Healthcare Biometrics Market, which was valued at USD 23.05 billion in 2023 and is anticipated to expand at a CAGR of 21.8%, reaching USD 136.02 billion by 2032 during the forecast period of 2024-2032.
-
Nov 8, 2024 | 
giiresearch.com | Clinical Laboratories
Global Bacterial Colony Counters Market was valued at USD 403.21 Million in 2023 and is expected to reach USD 534.74 Million by 2029 with a CAGR of 4.91% during the forecast period. The global bacterial colony counters market is experiencing significant growth driven by the increasing emphasis on food safety, healthcare quality control, and pharmaceutical applications.
-
Oct 16, 2024 | 
whatech.com | Clinical Laboratories
The global Healthcare Biometrics market size was valued at $5.2 billion in 2021, and is expected to reach $24.9 billion by 2031, growing at a CAGR of 17.4% from 2022 to 2031.
-
Sep 6, 2024 | 
giiresearch.com | Clinical Laboratories
Japan Precision Medicine Market was valued at USD 450.12 million in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 10.50% through 2030. The Japan Precision Medicine Market is a rapidly evolving sector within the healthcare industry, distinguished by its emphasis on customizing medical treatments to individual patient profiles based on genetic, molecular, and clinical data.
-
Jul 28, 2024 | 
alzres.biomedcentral.com | Cerdanyola del Vallès |Clinical Laboratories
The production of human recombinant ApoJ (rhApoJ) has been previously reported [18, 23, 24]. Briefly, transfected human embryonic kidney 293T cells (HEK293T) overexpressing rhApoJ were cultured in HYPERFlask systems (Corning Inc., Corning, NY, USA).
-
Jul 28, 2024 | 
link.springer.com | Cerdanyola del Vallès |Clinical Laboratories
AbstractCerebral amyloid angiopathy (CAA) is characterized by amyloid-β (Aβ) deposition in cerebral vessels, leading to lobar cerebral microbleeds (CMB) and intracerebral hemorrhages (ICH). Apolipoprotein J (ApoJ) is a multifunctional chaperone related to Aβ aggregation and clearance. Our study investigated the vascular impact of chronic recombinant human Apolipoprotein J (rhApoJ) treatment in a transgenic mouse model of β-amyloidosis with prominent CAA.
-
Jun 21, 2024 | 
giiresearch.com | Clinical Laboratories
Global Precision Diagnostics Market was valued at USD 14.18 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 16.48% through 2029.
-
May 29, 2024 | 
einpresswire.com | Clinical Laboratories
PORTLAND, OR, UNITED STATE, May 29, 2024 / EINPresswire.com/ -- Allied Market Research has recently published its latest research study titled 'Global Healthcare Biometrics Market Outlook and Forecast 2023-2032.' This comprehensive report conducts a thorough analysis of market risks, identifies promising opportunities, and offers valuable insights to support strategic and tactical decision-making from 2023 to 2032. The study divides the market into key regions that are driving its growth.
-
May 29, 2024 | 
menafn.com | Clinical Laboratories
Healthcare Biometrics Market Size, Top Companies, Share, Growth And Forecast 2033 CAGR 17.4% 5/29/2024 2:01:02 PM Healthcare Biometrics Market3 PORTLAND, OR, UNITED STATE, May 29, 2024 /EINPresswire / -- Allied market Research has recently published its latest research study titled 'Global Healthcare Biometrics market Outlook and Forecast 2023-2032.' This comprehensive report conducts a thorough analysis of market risks, identifies promising opportunities, and offers valuable insights to...
-
May 14, 2024 | 
academic.oup.com | Clinical Laboratories
To evaluate the utility of the dilute prothrombin time (DPT) in diagnosing antiphospholipid syndrome (APS), alone and when paired with the dilute Russell viper venom time (DRVVT). Dilute prothrombin time and DRVVT testing was performed on plasma samples spiked with apixaban or rivaroxaban, or depleted of vitamin K–dependent clotting factors. A retrospective analysis of all functional APS testing results over a 44-month period at the University of Chicago Medical Center was performed.
